By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > 6-7 Million Infected Globally Yet Chagas Disease Surveillance Remains Critically Underfunded

6-7 Million Infected Globally Yet Chagas Disease Surveillance Remains Critically Underfunded

GMJ
Last updated: 22/06/2026 10:17
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Healthcare workers reviewing Chagas disease surveillance data in Latin American clinic
New research identifies critical gaps in Chagas disease surveillance systems across Bolivia and Paraguay. The multi-level study offers actionable guidance for strengthening health data management in endemic regions. — Photo: Jair Lázaro / Pexels
SHARE
1 min read|121 words

While an estimated 6-7 million people worldwide carry Chagas disease infection, a new study in The Lancet Regional Health – Americas reveals that surveillance infrastructure in endemic countries remains inadequate. Researchers examining Bolivia and Paraguay documented critical gaps in routine data management systems across multiple healthcare levels, compromising the ability to monitor disease burden and control intervention effectiveness.

The majority of Chagas disease cases concentrate in Latin America, with particular burden in rural and impoverished communities. Despite the substantial global health impact—affecting 75 million people at risk—health information systems show persistent weaknesses in data collection and utilization. These findings highlight a troubling disconnect between disease burden and surveillance capacity, underscoring why targeted health system investments are essential for effective disease control.

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Multi-country study reveals critical gaps in Chagas disease data systems across Bolivia and Paraguay →

Related reference
  • Chagas disease · Condition
  • Chaga · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells

Researchers have identified that rare liver cancers evade immunotherapy by trapping immune…

Timing of Second Stent Placement After Heart Attack: New Trial Challenges Immediate Intervention Strategy

A randomized controlled trial published in the New England Journal of Medicine…

Africa’s Regional Research Hubs: Building Local Capacity for Drug Manufacturing and Health Innovation

Africa needs strategically distributed regional research and development hubs to accelerate local…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Clinical diagram showing necrotising fasciitis progression timeline and mortality risk by intervention speed

Time Is Tissue: How Early Surgical Intervention Transforms Necrotising Fasciitis Outcomes

By
Prof. Giorgi Pkhakadze
18/07/2026
UK Health Security Agency logo and laboratory equipment for communicable disease testing

UKHSA Birmingham Laboratory Unveils Standardised Protocols for NHS Microbiology Services

By
Prof. Giorgi Pkhakadze
22/07/2026
Infographic showing daily micronutrient targets for thyroid health: iodine 150 mcg, selenium 55-100 mcg, tyrosine 500-1000 mg

Announcement: Thyroid Health Requires Nutritional Balance: Why Iodine, Selenium, and Tyrosine Work as a System

By
Prof. Giorgi Pkhakadze
29/07/2026
Medical professional inspecting positive pressure breathing device in hospital setting

Critical Safety Alert: Baxter Volara Breathing Devices Show Air Leak Defects

By
Prof. Giorgi Pkhakadze
04/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up